Markets India

Paras Healthcare, India's recently-listed hospital chain, reported a net profit of Rs 40.35 crore in Q2 FY27, nearly tripling its Rs 12.38 crore profit in the same period last year. Shares rose 2.99% to Rs 774.35 on the BSE following the results.

Paras Healthcare Posts Rs 40.35 Crore Q2 Net Profit, Tripling YoY

Paras Healthcare's Q2 results mark a significant financial turnaround, with net profit nearly tripling year-over-year to Rs 40.35 crore, driven by improved operational efficiency and debt reduction. Revenue from operations reached Rs 510.89 crore, while expenses totaled Rs 463.12 crore. The company used Rs 375 crore of its Rs 500 crore IPO proceeds to repay borrowings and strengthen its balance sheet. Shares closed 2.99% higher at Rs 774.35 on the BSE, reflecting investor confidence in the post-IPO performance. The company's Managing Director, Dharminder Kumar Nagar, faces pressure to sustain growth as expansion plans could intensify competition in the healthcare sector. Strategic investments in advanced clinical technology and specialty programs in oncology, cardiac, neuro, and renal sciences are expected to drive long-term growth. However, the Brief notes no specific risks or opportunities beyond these plans.

Paras Healthcare plans to deepen specialty programs in oncology, cardiac, neuro, and renal sciences, invest in advanced clinical technology, and expand in North India. The company will continue to prioritize balance sheet strength and operational growth.

Paras Healthcare's Q2 results highlight strong post-IPO performance and operational efficiency, positioning it for growth in competitive healthcare markets.

Topics: Healthcare Sector, Financial Results, IPO Performance, Operational Efficiency, Share Price, Debt Reduction, Expansion Plans, Clinical Technology

#ParasHealthcare #Q2Results #NetProfit #IPOPerformance #HealthcareSector #DebtReduction #ExpansionPlans #ClinicalTechnology

Source: ET Markets